Formation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticles

被引:103
作者
Castro, Gisele A. [1 ]
Coelho, Anna Luiza L. R. [1 ]
Oliveira, Cleida A. [2 ]
Mahecha, German A. B. [2 ]
Orefice, Rodrigo L. [3 ]
Ferreira, Lucas A. M. [1 ]
机构
[1] Univ Fed Minas Gerais, Dept Pharmaceut, Fac Pharm, BR-31270901 Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Dept Morphol, BR-31270901 Belo Horizonte, MG, Brazil
[3] Univ Fed Minas Gerais, Dept Met & Mat Engn, BR-31270901 Belo Horizonte, MG, Brazil
关键词
Solid lipid nanoparticles; Retinoic acid; Acne; Topical treatment; Ion pairing; Skin irritation; TOPICAL TREATMENT; DRUG-DELIVERY; ACNE-VULGARIS; TRETINOIN; SLN; FORMULATION;
D O I
10.1016/j.ijpharm.2009.07.025
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This work aims to investigate the influence of the formation of ion pairing between all-trans retinoic acid (RA) and a lipophilic amine (stearylamine; STE) on the drug encapsulation efficiency (EE) and stability of solid lipid nanoparticles (SLNs). The SLNs were characterized for EE and size. The EE and particle size were significantly improved and reduced, respectively, when the surfactant or co-surfactant concentration increased. However, while the formulation without STE allowed only 13% of RA encapsulation, the EE for RA-STE-loaded SLNs was 94%. The stability studies showed a significant decrease in EE for the SLNs without STE, while, for SLNs loaded with IRA and STE, the EE remained constant after 360 days. The interactions among ion pairing components and the lipid matrix were investigated through small-angle X-ray scattering (SAXS). The SAXS analysis revealed the presence of RA in the crystalline form in SLNs without ion pairing, while crystalline RA was not observed in SLNs loaded with RA/amine. Skin irritation studies showed that the SLNs loaded with the ion pairing were significantly less irritating when compared to the marketed RA-cream. This novel SLN formulation represents a promising alternative for topical treatment of acne with RA. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:77 / 83
页数:7
相关论文
共 30 条
[1]   Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering [J].
Bunjes, Heike ;
Unruh, Tobias .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (06) :379-402
[2]   Novel vesicular and particulate drug delivery systems for topical treatment of acne [J].
Castro, Gisele A. ;
Ferreira, Lucas A. M. .
EXPERT OPINION ON DRUG DELIVERY, 2008, 5 (06) :665-679
[3]   Characterization of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne [J].
Castro, Gisele A. ;
Ferreira, Lucas A. M. ;
Orefice, Rodrigo L. ;
Buono, Vicente T. L. .
POWDER DIFFRACTION, 2008, 23 (02) :S30-S35
[4]   Development of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne [J].
Castro, Gisele A. ;
Orefice, Rodrigo L. ;
Vilela, Jose M. C. ;
Andrade, Margareth S. ;
Ferreira, Lucas A. M. .
JOURNAL OF MICROENCAPSULATION, 2007, 24 (05) :395-407
[5]   In vitro percutaneous absorption of all-trans retinoic acid applied in free form or encapsulated in stratum corneum lipid liposomes [J].
Contreras, MJF ;
Soriano, MMJ ;
Diéguez, AR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 297 (1-2) :134-145
[6]   Production of solid lipid nanoparticles (SLN): scaling up feasibilities [J].
Dingler, A ;
Gohla, S .
JOURNAL OF MICROENCAPSULATION, 2002, 19 (01) :11-16
[7]  
Ellis CN, 1998, BRIT J DERMATOL, V139, P41
[8]   Topical drug treatment in acne [J].
Gollnick, H ;
Schramm, M .
DERMATOLOGY, 1998, 196 (01) :119-125
[9]   Management of acne - A report from a global alliance to improve outcomes in acne [J].
Gollnick, H ;
Cunliffe, W ;
Berson, D ;
Dreno, B ;
Finlay, A ;
Leyden, JJ ;
Shalita, AR ;
Thiboutot, D .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 49 (01) :S1-S37
[10]   Solid lipid namoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs [J].
Hu, LD ;
Tang, X ;
Cui, FD .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 (12) :1527-1535